ArticleBMC ophthalmology2025
A rare case of Blepharophimosis-Ptosis-Epicanthus inversus syndrome (BPES) associated with keratoconus: a multidisciplinary approach to diagnosis and management.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBlepharophimosis-Ptosis-Epicanthus Inversus Syndrome (BPES) is a rare congenital condition typically associated with mutations in the FOXL2 gene. It is characterized by eyelid malformations and, in some cases, premature ovarian insufficiency. Although visual complications such as astigmatism and amblyopia are well recognized, an association between BPES-like features and keratoconus has not been previously reported. CASE PRESENTATION: We report a 41-year-old Saudi female presenting with progressive visual decline and congenital eyelid abnormalities. Clinical evaluation revealed features consistent with BPES, and corneal topography confirmed bilateral keratoconus. Genetic testing identified a homozygous pathogenic variant in the COLEC10 gene, with no FOXL2 mutations detected. A multidisciplinary management plan involving oculoplasty consult, corneal rehabilitation, and endocrine evaluation was implemented.
conclusionThis case represents a novel association between a COLEC10 mutation and a BPES-like phenotype with coexisting keratoconus. The findings suggest a potential genetic and mechanical basis for corneal ectasia in patients with congenital eyelid anomalies. The absence of FOXL2 involvement emphasizes the importance of broad genetic testing in atypical presentations. Routine corneal imaging and comprehensive genetic analysis should be considered in patients with syndromic eyelid malformations. This case expands the clinical spectrum of COLEC10-related disorders and supports the need for further research into its role in ocular development and corneal biomechanics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.